Former Chief Medical Officer · Cidara Therapeutics, Inc. (CDAR)

Taylor Sandison

A named executive officer of Cidara Therapeutics in every fiscal year CompBrief holds from FY2023 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$2,015,225

Salary $505,100Stock awards $88,174

FY2023: $884,092

3rd of 3 named executive officers at Cidara Therapeutics by FY2024 total.

3 named officers on file for Cidara Therapeutics, FY2024

Taylor Sandison’s pay file — $29

  • 2 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Cidara Therapeutics’s whole pay program stands against its peers

  • Cidara Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CDAR→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 25, 2025 (DEF 14A).

Free

Get Taylor Sandison’s full pay file as a PDF — free

More than this page: up to 10 years of Taylor’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Taylor Sandison compensation by year

Cidara Therapeutics Summary Compensation Table · all 2 fiscal years held
In US dollars, as Cidara Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2023FY2024
Salary$487,100$505,100
Bonus$0—
Stock awards$90,900$88,174
Option awards$128,592$1,411,601
Non-equity incentive$167,600$0
Pension and deferred compensation$0—
All other$9,900$10,350
Total$884,092$2,015,225

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Cidara Therapeutics, Inc. DEF 14A filed April 25, 2025, accession 0001610618-25-000040, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Cidara Therapeutics, Inc. filed document, accession 0001610618-25-000040. Every figure is read from that document and cited to the page and table it appears in. Filed April 25, 2025.

$884K
$2.0M
FY23
FY24
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
RSU6,437$173,027—
RSU3,000$80,640—
RSU825$22,176—
Option414—$16.65
Option3,750—$20.20
Option8,824—$13.70
Option152,933—$10.75

Per the Outstanding Equity Awards at Fiscal Year-End table in Cidara Therapeutics, Inc.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.

Cidara Therapeutics’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Jeffrey SteinPresident and Chief Executive Officer$5,965,903
Leslie TariChief Scientific Officer$2,040,404
Taylor Sandison · this pageFormer Chief Medical Officer$2,015,225

The full Cidara Therapeutics compensation record

free company brief

This page is one person within Cidara Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Cidara Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Taylor Sandison's compensation dossier · One-time report. No refunds.